Phreesia (PHR) Stock Forecast & Price Target

Compare

341 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PHR Analyst Ratings

Strong Buy

12 Buy

0 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Phreesia

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PHR Stock 12 Month Forecast

Average Price Target

$30.09

▲(83.36% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Phreesia in the last 3 months. The average price target is $30.09 with a high forecast of $35.00 and a low forecast of $24.00. The average price target represents a 83.36% change from the last price of $16.41.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","36":"$36","21.75":"$21.8","26.5":"$26.5","31.25":"$31.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.09,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,21.75,26.5,31.25,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.01,21.163076923076925,22.316153846153846,23.46923076923077,24.622307692307693,25.775384615384617,26.92846153846154,28.08153846153846,29.234615384615385,30.38769230769231,31.54076923076923,32.69384615384615,33.846923076923076,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.01,20.78538461538462,21.560769230769232,22.33615384615385,23.111538461538462,23.88692307692308,24.662307692307692,25.43769230769231,26.213076923076922,26.98846153846154,27.763846153846153,28.53923076923077,29.314615384615387,{"y":30.09,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.01,20.31692307692308,20.623846153846156,20.930769230769233,21.23769230769231,21.544615384615387,21.85153846153846,22.158461538461538,22.465384615384615,22.77230769230769,23.07923076923077,23.386153846153846,23.693076923076923,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.47,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.1,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.16,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.23,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.48,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.64,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.01,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$30.09

Lowest Price Target$24.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Glen Santangelo

Barclays

$26→$24

Buy

46.25%

Upside

Reiterated

12/16/25

Barclays Sticks to Their Buy Rating for Phreesia (PHR)

Sean Dodge

BMO Capital

$32

Buy

95.00%

Upside

Assigned

12/12/25

BMO Capital Sticks to Its Buy Rating for Phreesia (PHR)

Jailendra Singh

Truist Financial

$36→$29

Buy

76.72%

Upside

Reiterated

12/11/25

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Agios Pharma (NASDAQ: AGIO) and Phreesia (NYSE: PHR)

Joseph Vruwink

Robert W. Baird

$31→$25

Buy

52.35%

Upside

Reiterated

12/10/25

Phreesia price target lowered to $25 from $31 at BairdPhreesia price target lowered to $25 from $31 at Baird

Steven Valiquette

Mizuho Securities

$36→$28

Buy

70.63%

Upside

Reiterated

12/10/25

Phreesia price target lowered to $28 from $36 at MizuhoPhreesia price target lowered to $28 from $36 at Mizuho

Richard Close

Canaccord Genuity

$38→$33

Buy

101.10%

Upside

Reiterated

12/09/25

Canaccord Genuity Sticks to Its Buy Rating for Phreesia (PHR)

Alexei Gogolev

J.P. Morgan

$32→$29

Buy

76.72%

Upside

Reiterated

12/09/25

Phreesia price target lowered to $29 from $32 at JPMorganPhreesia price target lowered to $29 from $32 at JPMorgan

Ryan Daniels

William Blair

Buy

―

Reiterated

12/09/25

Phreesia's Strong Financial Performance and Strategic Initiatives Justify Buy Rating

Daniel Grosslight

Citi

$34→$29

Buy

76.72%

Upside

Reiterated

12/09/25

Phreesia price target lowered to $29 from $34 at CitiPhreesia price target lowered to $29 from $34 at Citi

Clark Wright

D.A. Davidson

$35

Buy

113.28%

Upside

Reiterated

12/09/25

Analysts' Top Healthcare Picks: Phreesia (PHR), Wave Life Sciences (WVE)

Ryan MacDonald

Needham

$35

Buy

113.28%

Upside

Reiterated

12/09/25

Phreesia's Strategic Growth and Financial Performance Drive Buy Rating Amid Attractive Valuation

Scott Schoenhaus

KeyBanc

$35→$32

Buy

95.00%

Upside

Reiterated

10/08/25

Phreesia price target lowered to $32 from $35 at KeyBancPhreesia price target lowered to $32 from $35 at KeyBanc

Aaron Kimson

Citizens JMP

$30→$34

Buy

107.19%

Upside

Reiterated

09/08/25

Phreesia price target raised to $34 from $30 at Citizens JMPPhreesia price target raised to $34 from $30 at Citizens JMP

John Ransom

Raymond James

$30→$33

Buy

101.10%

Upside

Reiterated

09/05/25

Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating

Jessica Tassan

Piper Sandler

$33→$34

Buy

107.19%

Upside

Reiterated

09/05/25

Phreesia price target raised to $34 from $33 at Piper SandlerPhreesia price target raised to $34 from $33 at Piper Sandler

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Glen Santangelo

Barclays

$26→$24

Buy

46.25%

Upside

Reiterated

12/16/25

Barclays Sticks to Their Buy Rating for Phreesia (PHR)

Sean Dodge

BMO Capital

$32

Buy

95.00%

Upside

Assigned

12/12/25

BMO Capital Sticks to Its Buy Rating for Phreesia (PHR)

Jailendra Singh

Truist Financial

$36→$29

Buy

76.72%

Upside

Reiterated

12/11/25

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Agios Pharma (NASDAQ: AGIO) and Phreesia (NYSE: PHR)

Joseph Vruwink

Robert W. Baird

$31→$25

Buy

52.35%

Upside

Reiterated

12/10/25

Phreesia price target lowered to $25 from $31 at BairdPhreesia price target lowered to $25 from $31 at Baird

Steven Valiquette

Mizuho Securities

$36→$28

Buy

70.63%

Upside

Reiterated

12/10/25

Phreesia price target lowered to $28 from $36 at MizuhoPhreesia price target lowered to $28 from $36 at Mizuho

Richard Close

Canaccord Genuity

$38→$33

Buy

101.10%

Upside

Reiterated

12/09/25

Canaccord Genuity Sticks to Its Buy Rating for Phreesia (PHR)

Alexei Gogolev

J.P. Morgan

$32→$29

Buy

76.72%

Upside

Reiterated

12/09/25

Phreesia price target lowered to $29 from $32 at JPMorganPhreesia price target lowered to $29 from $32 at JPMorgan

Ryan Daniels

William Blair

Buy

―

Reiterated

12/09/25

Phreesia's Strong Financial Performance and Strategic Initiatives Justify Buy Rating

Daniel Grosslight

Citi

$34→$29

Buy

76.72%

Upside

Reiterated

12/09/25

Phreesia price target lowered to $29 from $34 at CitiPhreesia price target lowered to $29 from $34 at Citi

Clark Wright

D.A. Davidson

$35

Buy

113.28%

Upside

Reiterated

12/09/25

Analysts' Top Healthcare Picks: Phreesia (PHR), Wave Life Sciences (WVE)

Ryan MacDonald

Needham

$35

Buy

113.28%

Upside

Reiterated

12/09/25

Phreesia's Strategic Growth and Financial Performance Drive Buy Rating Amid Attractive Valuation

Scott Schoenhaus

KeyBanc

$35→$32

Buy

95.00%

Upside

Reiterated

10/08/25

Phreesia price target lowered to $32 from $35 at KeyBancPhreesia price target lowered to $32 from $35 at KeyBanc

Aaron Kimson

Citizens JMP

$30→$34

Buy

107.19%

Upside

Reiterated

09/08/25

Phreesia price target raised to $34 from $30 at Citizens JMPPhreesia price target raised to $34 from $30 at Citizens JMP

John Ransom

Raymond James

$30→$33

Buy

101.10%

Upside

Reiterated

09/05/25

Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating

Jessica Tassan

Piper Sandler

$33→$34

Buy

107.19%

Upside

Reiterated

09/05/25

Phreesia price target raised to $34 from $33 at Piper SandlerPhreesia price target raised to $34 from $33 at Piper Sandler

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Phreesia

1 Month

xxx

Success Rate

8/12 ratings generated profit

Average Return

+1.27%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.27% per trade.

3 Months

xxx

Success Rate

9/16 ratings generated profit

Average Return

+0.33%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +0.33% per trade.

1 Year

Jailendra SinghTruist Financial

Success Rate

7/15 ratings generated profit

Average Return

-5.38%

reiterated a buy rating 10 days ago

Copying Jailendra Singh's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -5.38% per trade.

2 Years

xxx

Success Rate

3/12 ratings generated profit

Average Return

-20.40%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -20.40% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PHR Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PHR has received 19 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. PHR average Analyst price target in the past 3 months is 30.09.

Each month's total comprises the sum of three months' worth of ratings.

PHR Financial Forecast

PHR Earnings Forecast

Next quarter’s earnings estimate for PHR is $0.06 with a range of -$0.01 to $0.19. The previous quarter’s EPS was $0.07. PHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PHR has Performed in-line its overall industry.

PHR Sales Forecast

Next quarter’s sales forecast for PHR is $126.84M with a range of $125.90M to $127.38M. The previous quarter’s sales results were $120.33M. PHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PHR has Performed in-line its overall industry.

PHR Stock Forecast FAQ

What is PHR’s average 12-month price target, according to analysts?

Based on analyst ratings, Phreesia’s 12-month average price target is 30.09.

What is PHR’s upside potential, based on the analysts’ average price target?

Phreesia has 83.36% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PHR a Buy, Sell or Hold?

Phreesia has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.

What is Phreesia’s price target?

The average price target for Phreesia is 30.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $24.00. The average price target represents 83.36% Increase from the current price of $16.41.

What do analysts say about Phreesia?

Phreesia’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of PHR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Phreesia (PHR) Stock Forecast & Price Target

PHR Analyst Ratings

PHR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Phreesia

PHR Analyst Recommendation Trends

PHR Financial Forecast

PHR Earnings Forecast

PHR Sales Forecast

PHR Stock Forecast FAQ

Detailed List of Analyst Forecasts